Novel transcript, antisense to ANKMY2

ENSG00000287799 encodes a long non-coding RNA (lncRNA) annotated as "novel transcript, antisense to ANKMY2." It is classified as an antisense transcript due to its orientation opposite to the ANKMY2 protein-coding gene. lncRNAs of this kind may participate in regulation of local gene expression through RNA-RNA interactions or modulation of chromatin, but there is currently no functional or disease association reported in the scientific literature for this specific lncRNA. It is not recognized as a drug target or biomarker, nor are there described interactions with small molecules or approved therapies[3][5]. No evidence suggests a naming or conceptual error, although for therapeutic research and clinical applications this entity is not a traditional target[3][5].

Other names

lnc-ANKMY2-1